A chronic form of eczema that develops specifically in the hands now has its first approved FDA-approved drug, a topical cream from dermatological ...

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the ...

AI has quickly been moving through the pharmaceutical industry, where professionals are seeing clear value – from shortening the drug development ...

Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a platform technology that ...

As MedCity News continues to grow our multimedia content from informative articles on the business of healthcare innovation, podcasts such as ...

Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the ...

Weight management remains a popular topic in our society. This doesn’t come as a surprise, as reports indicate that obesity affects nearly 43% of ...

Biologic medicines are making inroads into chronic obstructive pulmonary disease (COPD), with two blockbuster antibodies expanding their ...

For the third time this year, a patient treated with a Sarepta Therapeutics gene therapy has died, a revelation that comes as the company tries to ...

Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to ...

A Kura Oncology and Kyowa Kirin-partnered drug vying to become the first FDA-approved treatment for cases of acute myeloid leukemia (AML) carrying ...